# Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/regorafenib-plus-best-supportive-care-versus-placebo-plus-best-supportive-care/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jin Li,Shukui Qin,Rui‐Hua Xu,Thomas Yau,Brigette Ma,Hongming Pan,Jianming Xu,Yuxian Bai,Yihebali Chi,Liwei Wang,Kun‐Huei Yeh,Feng Bi,Ying Cheng,Anh T. Le,Jen-Kou Lin,Tianshu Liu,Dong Ma,Christian Kappeler,J. Kalmus,Tae Won Kim |
| Citations | 822 |
| DOI | 10.1016/s1470-2045(15)70156-7 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2111851685 |
| PMID | 25981818 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.